2017 annual financial data
Avalo Therapeutics 2017 Operating margin
Avalo Therapeutics 2017 operating margin with verified reported values.
Direct answer
Operating margin was 49.94%.
Operating income was 13,889,982 USD and net income was 11,869,823 USD.
Operating cash flow was 12,519,405 USD.
Get free Avalo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 27,813,137 USD
- Operating income
- 13,889,982 USD
- Net income
- 11,869,823 USD
- Operating cash flow
- 12,519,405 USD